AstraZeneca shakes up management
January 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Mackay, R&D, Soriot
AstraZeneca has taken its most dramatic steps yet to arrest decline, with chief executive Pascal Soriot axeing two senior positions …
Sanofi Pasteur MSD appoint president of Vaccines Europe
January 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrea Rappagliosi, Sanofi pasteur msd, vaccines
Vice president of Market Access, Health Policy & Medical Affairs at Sanofi Pasteur MSD Andrea Rappagliosi has been appointed president …
Boehringer in oncology tie-up
January 16, 2013Research and Development, Sales and Marketing Boehringer, Cancer, horizon, x-man
Boehringer Ingelheim has entered a five-year tie-up with a UK biotech company which specialises in helping research into personalised medicines. …
NICE consults on tamoxifen
January 15, 2013Sales and Marketing Cancer, Evista, NICE, lilly, tamoxifen
Patient groups have welcomed NICE’s new draft guideline recommending the use of preventive treatments in women who have a family …
Mitsubishi deal to buy Qualicaps will close in March
January 15, 2013Manufacturing and Production Mitsubishi, Patheon, Qualicaps
Mitsubishi Chemical has agreed to buy Qualicaps from US private equity company Carlyle Group in the latest round of M&A …
Zytiga extended in EU
January 15, 2013Sales and Marketing EU, J&J, JJ, Janssen, Zytiga
Janssen is celebrating the European Commission’s decision to extend the licence for its prostate cancer treatment Zytiga. The once-daily pill …
Pharma manufacturing news in brief
January 14, 2013Manufacturing and Production ADMA, Biotest, Catalent, Emerson, Nanocarrier, Orient Europharma, UCB
Facility news from Orient Europharma/NanoCarrier, Catalent and China Biologic, plus new contracts for Emerson Process Management and Biotest Pharma.
FDA publishes guidance on abuse-resistant opioids
January 14, 2013Manufacturing and Production CDC, FDA, hamburg, opioids
The US Food and Drug Administration has issued draft guidance designed to combat the escalating problem of abuse of prescription …
Lonza earmarks $15m for ADC plant expansion
January 14, 2013Manufacturing and Production ADC, API, Lonza, Novasep
Swiss contract manufacturer Lonza has said it will invest around 14 million francs ($15m) in new capacity for antibody drug …
Kathryn Gallant joins Insight Health US as joint chief executive
January 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gallant, insight health
The former managing partner for US health at Hall & Partners has joined the consultancy firm Insight Health US as …
Eisai cancer drug fails
January 14, 2013Research and Development, Sales and Marketing Cancer, Eisai, Morphotek, farletuzumab
Eisai’s investigational oncology treatment farletuzumab has failed to reach its primary endpoint in a late-stage trial. Farletuzumab (MORAb-003) did not …
Merck withdraws Tredaptive
January 14, 2013Sales and Marketing EMA, Merck, tredaptive
Merck is mounting a global operation to withdraw its cholesterol-lowering drug Tredaptive from the market following safety concerns. The company …
Dominic Atkins joins Clinigen GAP in senior commercial role
January 14, 2013Manufacturing and Production, Research and Development, Sales and Marketing Clinigen, Dominic Atkins
Pharma services company Clinigen Global Access Programs (Clinigen GAP) has appointed Dominic Atkins as global business development director. In this …
Janssen’s diabetes drug Invokana recommended
January 11, 2013Sales and Marketing Janssen, SGLT2, canagliflozin, diabetes, invokana
An FDA advisory committee has recommended Janssen’s new diabetes treatment canagliflozin for approval. To be marketed under the name Invokana, …
EU submission for GSK and Theravance COPD drug
January 11, 2013Sales and Marketing COPD, GSK, Theravance, UMEC/VI
GlaxoSmithKline and Theravance have submitted their chronic obstructive pulmonary disease (COPD) drug UMEC/VI to European regulators. The application follows the …
Lundbeck appoints new global pricing and market access VP
January 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eggert, Jaszewski, Lundbeck
Barbara Jaszewski, has been appointed vice president of global pricing and market access at Lundbeck. She will be in charge …
Public health budget ring-fenced
January 11, 2013Sales and Marketing Hunt, NHS, government
Local authorities are to receive a total of £5.45 billion from the government over the next two years to spend …
Cherwell appoints product specialist
January 11, 2013Manufacturing and Production, Research and Development, Sales and Marketing Cherwell Laboratories
Pharma supplier firm Cherwell Laboratories has announced the appointment of Abdulmajeed Raji as microbiology product specialist. Prior to joining Cherwell, …
FDA vote on J&J diabetes drug
January 10, 2013Sales and Marketing EU, FDA, J&J, JJ, Janssen, canagliflozin
Key advisers to the FDA are meeting today to decide whether Janssen Pharmaceuticals’ type II diabetes drug canagliflozin is safe …
Hookipa Biotech hires two officers
January 10, 2013Manufacturing and Production, Research and Development, Sales and Marketing Farshad Guirakhoo, Hookipa, Thomas Monarth
Vaccines biotech firm Hookipa Biotech AG has appointed two new members to its management team. Thomas Monath (pictured) joins as …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
